Smith & Nephew Snats ((SNN)) announced an update on their ongoing clinical study.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Smith & Nephew is conducting a clinical study titled ‘Evaluation of Safety and Efficacy of a Resorbable Collagen Implant in Treatment of High Grade Partial Thickness Tears; A Prospective, Multicenter, Randomized, Control Trial (IMPACT Study)’. The study aims to determine if the REGENETEN™ Bioinductive Implant can help patients resume daily activities faster compared to the standard ‘Completion and Repair’ technique for treating partial-thickness rotator cuff tears. This research is significant as it could potentially improve recovery times for individuals with rotator cuff injuries.
The interventions being tested include the REGENETEN™ Bioinductive Implant, a device designed for surgical treatment of partial-thickness rotator cuff tears, and the standard ‘Completion and Repair’ procedure. The REGENETEN™ system is intended to enhance the healing process and reduce recovery time.
The study design is interventional, with participants randomly assigned to either the experimental group receiving the REGENETEN™ implant or the active comparator group undergoing the standard procedure. It follows a parallel intervention model with single masking, where only the participants are unaware of the group allocation. The primary purpose of the study is treatment-focused.
The study began on June 29, 2022, and is currently recruiting participants. The primary completion date and estimated study completion date are yet to be announced, with the last update submitted on May 6, 2025. These dates are crucial for tracking the study’s progress and anticipating when results might be available.
The outcome of this study could influence Smith & Nephew’s stock performance and investor sentiment, as successful results may enhance the company’s market position in the medical device industry. Competitors in the orthopedic and medical device sectors will likely monitor these developments closely.
The study is ongoing, and further details are available on the ClinicalTrials portal.